Cytocom
Winter Park, US · Delaware corporation
Founders & leadership
PA
Peter AronstamNamed on SEC filing
NM
Noreen McGurrin GriffinNamed on SEC filing
MH
Michael HandleyNamed on SEC filing
CM
Cozette McAvoyNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.3M disclosed across 1 of 2 rounds · 2020–2021
▶$6MofferedJan 2021 · 6 investors · BiotechnologyRule 506(b)
▶$6MofferedJan 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter AronstamExecutive Officer
- Taunia MarkvickaExecutive Officer, Director
- Clifford SelskyExecutive Officer
- Noreen GriffinExecutive Officer, Director
- Cozette McAvoyExecutive Officer
- Michael K HandleyExecutive Officer, Director
- Offering amount
- $6M
- Proceeds to insiders
- $6M
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.3MraisedJul 2020 · 10 investors · BiotechnologyRule 506(b)
▶$2.3MraisedJul 2020 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter AronstamExecutive Officer
- Noreen McGurrin GriffinExecutive Officer, Director
- Michael HandleyExecutive Officer, Director
- Cozette McAvoyExecutive Officer
- Offering amount
- $15M
- Amount sold
- $2.3M
- Minimum investment
- $25K
- Proceeds to insiders
- $15M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cytocom raised?
- Cytocom has disclosed $2.3M raised across 1 of its 2 known rounds.
- Where is Cytocom headquartered?
- Cytocom is headquartered in Winter Park, US.